InvestSMART

Company announcements

leave blank for all companies
leave blank for all announcements
announcements

~ We have limited the announcement data displayed on our website to the past 12 months to ensure its accuracy and usefulness.
Search Results
Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 28 Apr 2025 9:08AM $11.340 $12.420 risen by 9.52%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Virtual AGM online guide 24 Apr 2025 9:26AM $11.010 $12.420 risen by 12.81%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Notice of Annual General Meeting/Proxy Form 24 Apr 2025 9:20AM $11.010 $12.420 risen by 12.81%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 24 Apr 2025 8:53AM $11.010 $12.420 risen by 12.81%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 23 Apr 2025 7:59AM $10.390 $12.420 risen by 19.54%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 22 Apr 2025 8:42AM $10.530 $12.420 risen by 17.95%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 17 Apr 2025 8:36AM $10.170 $12.420 risen by 22.12%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Change of Director's Interest Notice - J Basile 16 Apr 2025 4:52PM $10.170 $12.420 risen by 22.12%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 NEU confirms primary endpoints for Phase 3 trial in PMS 14 Apr 2025 8:58AM $9.190 $12.420 risen by 35.15%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 7 Apr 2025 8:26AM $9.860 $12.420 risen by 25.96%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 4 Apr 2025 9:03AM $10.570 $12.420 risen by 17.50%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Notification of cessation of securities - NEU 3 Apr 2025 8:21AM $10.810 $12.420 risen by 14.89%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 3 Apr 2025 7:56AM $10.810 $12.420 risen by 14.89%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Appendix 4G 3 Apr 2025 7:53AM $10.810 $12.420 risen by 14.89%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 2024 Annual Report to shareholders 3 Apr 2025 7:51AM $10.810 $12.420 risen by 14.89%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 2 Apr 2025 8:31AM $11.350 $12.420 risen by 9.43%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 1 Apr 2025 8:49AM $11.930 $12.420 risen by 4.11%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 31 Mar 2025 9:06AM $12.260 $12.420 risen by 1.31%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 28 Mar 2025 8:55AM $12.010 $12.420 risen by 3.41%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Neuren initiates development of NNZ-2591 to treat HIE 27 Mar 2025 9:36AM $11.930 $12.420 risen by 4.11%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 27 Mar 2025 8:55AM $11.930 $12.420 risen by 4.11%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 26 Mar 2025 8:30AM $12.620 $12.420 fallen by 1.58%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 25 Mar 2025 8:18AM $12.470 $12.420 fallen by 0.40%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 24 Mar 2025 8:47AM $12.550 $12.420 fallen by 1.04%
Neuren Pharmaceuticals Limited (NEU)
ORDINARY FULLY PAID
Health Care $1,571 Update - Notification of buy-back - NEU 21 Mar 2025 7:30AM $12.600 $12.420 fallen by 1.43%

101 - 125 of 800 results

Page 5 of 32

  • + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.